Steve Van Wormer 6/2/25 Steve Van Wormer 6/2/25

YUTREPIA: A New FDA Approved Treatment for PAH & PH-ILD

I’m Aware That I’m Rare: the phaware® podcast
Episode 523 - Rodolfo Estrada, MD

Dr. Rodolfo Estrada, is a seasoned pulmonologists currently at UT Health San Antonio with significant experience in the management of patients with different forms of pulmonary hypertension. In this episode Dr. Estrada will discuss the technology and clinical development behind YUTREPIA™ (treprostinil) inhalation powder and why it might be a good option for some PAH and PH-ILD patients.

Steve Van Wormer 5/26/25 Steve Van Wormer 5/26/25

Decoding Echo & Right Heart Cath Readings for Pulmonologists

I’m Aware That I’m Rare: the phaware® podcast
Episode 522 - Marc Simon MD

Decoding Pulmonary Hypertension: Echo and Cath Insights for Pulmonologists. Dr. Marc Simon shares his expertise on diagnosing pulmonary hypertension, emphasizing echocardiographic markers, right heart catheterization pitfalls, and risk stratification with the H2FPEF score. His insights help clinicians refine their diagnostic approach for better patient outcomes.

Steve Van Wormer 5/19/25 Steve Van Wormer 5/19/25

Clinical Trials: Pushing the Field Forward in PH-ILD

I’m Aware That I’m Rare: the phaware® podcast
Episode 521 - Jean Elwing, MD

Dr. Jean Elwing, a leading expert in pulmonary hypertension, discusses groundbreaking advancements in treating pulmonary hypertension associated with interstitial lung disease (PH-ILD). For years, patients with this condition had limited treatment options beyond oxygen therapy and symptom management. However, recent studies have introduced new hope, showing improved patient outcomes and quality of life. Dr. Elwing emphasizes the importance of early diagnosis, ongoing research, and clinical trial participation in pushing the field forward.

Steve Van Wormer 5/12/25 Steve Van Wormer 5/12/25

The Evolution of Inhaled Therapies: PRINT® Technology

I’m Aware That I’m Rare: the phaware® podcast
Episode 520 - Seth Hall, MBA, RRT

Seth Hall, MBA, RRT, takes listeners on a journey through the past, present, and future of inhaled therapies. Discover how these treatments have evolved, the life-changing benefits they offer, and the revolutionary technologies that could redefine outcomes for PAH and PH-ILD patients.

Steve Van Wormer 5/5/25 Steve Van Wormer 5/5/25

PH-ILD Breakthroughs: New Therapies Changing Lives

I’m Aware That I’m Rare: the phaware® podcast
Episode 519 - Richard Channick, MD

Dr. Richard Channick, dives into the evolving world within pulmonary hypertension - interstitial lung disease (PH-ILD). He sheds light on why early diagnosis matters and how new therapies are transforming care. Learn about the latest FDA-approved treatment and what’s on the horizon.

Steve Van Wormer 4/28/25 Steve Van Wormer 4/28/25

A New Era in PH-ILD Treatment and Research

I’m Aware That I’m Rare: the phaware® podcast
Episode 518 - Ioana Preston, MD

Dr. Ioana Preston explores the emerging field of pulmonary hypertension associated with interstitial lung disease (PH-ILD). She discusses the growing recognition of PH-ILD, especially after the introduction of inhaled treprostinil as a treatment, and highlights the importance of early screening and diagnosis. Dr. Preston also delves into the challenges of treating rare diseases, the evolution of research, and the hope for future therapies that could significantly improve patients’ lives. This insightful conversation sheds light on a critical yet often overlooked aspect of pulmonary care, urging clinicians to stay vigilant and informed about PH-ILD’s complexities.

Steve Van Wormer 4/21/25 Steve Van Wormer 4/21/25

Early Intervention Matters: The PH-ILD Detection Tool

I’m Aware That I’m Rare: the phaware® podcast
Episode 517 - Raj Parikh, MD

Dr. Raj Parikh from Hartford Hospital discusses the development of the PH-ILD Detection tool, a screening tool designed to help detect pulmonary hypertension (PH) in patients with interstitial lung disease (ILD) at an early stage. Early detection is critical, as there is often a significant delay in diagnosis of PH in ILD patients, leading to worsened outcomes.

Steve Van Wormer 4/7/25 Steve Van Wormer 4/7/25

The Future of Pulmonary Hypertension Treatment

I’m Aware That I’m Rare: the phaware® podcast
Episode 515 - Rajan Saggar, MD

For decades, researchers have sought better treatments for pulmonary hypertension in interstitial lung disease, a condition that drastically impacts patients’ quality of life. In this episode, Dr. Rajan Saggar dives into the latest advancements, including new inhaled medications, upcoming clinical trials, and the push for more personalized treatment approaches.

I’m Aware That I’m Rare: the phaware® podcastEpisode 523 - Rodolfo Estrada, MD

I’m Aware That I’m Rare: the phaware® podcastEpisode 522 - Marc Simon MD

I’m Aware That I’m Rare: the phaware® podcastEpisode 521 - Jean Elwing, MD

I’m Aware That I’m Rare: the phaware® podcastEpisode 520 - Seth Hall, MBA, RRT

I’m Aware That I’m Rare: the phaware® podcastEpisode 519 - Richard Channick, MD

I’m Aware That I’m Rare: the phaware® podcastEpisode 518 - Ioana Preston, MD

I’m Aware That I’m Rare: the phaware® podcastEpisode 517 - Raj Parikh, MD

I’m Aware That I’m Rare: the phaware® podcastEpisode 515 - Rajan Saggar, MD